Off-target effects of SGLT2 blockers: empagliflozin does not inhibit Na+/H+ exchanger-1 or lower [Na+]i in the heart

Yu Jin Chung; Kyung Chan Park; Sergiy Tokar; Thomas Eykyn; William Fuller; Davor Pavlovic; Pawel Swietach; Michael J Shattock

Off-target effects of SGLT2 blockers: empagliflozin does not inhibit Na+/H+ exchanger-1 or lower [Na+]i in the heart

Yu Jin Chung, Kyung Chan Park, Sergiy Tokar, Thomas Eykyn, William Fuller, Davor Pavlovic, Pawel Swietach, Michael J Shattock

Cardiovascular Sciences

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Cardiovascular Research
Publication status	Published - 2 Nov 2020

Access to Document

https://doi.org/10.1093/cvr/cvaa323

Cite this

@article{99276f19dafe42e6af7cbcf03488bceb,

title = "Off-target effects of SGLT2 blockers: empagliflozin does not inhibit Na+/H+ exchanger-1 or lower [Na+]i in the heart",

author = "Chung, {Yu Jin} and Park, {Kyung Chan} and Sergiy Tokar and Thomas Eykyn and William Fuller and Davor Pavlovic and Pawel Swietach and Shattock, {Michael J}",

year = "2020",

month = nov,

day = "2",

language = "English",

journal = "Cardiovascular Research",

issn = "0008-6363",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Off-target effects of SGLT2 blockers: empagliflozin does not inhibit Na+/H+ exchanger-1 or lower [Na+]i in the heart

AU - Chung, Yu Jin

AU - Park, Kyung Chan

AU - Tokar, Sergiy

AU - Eykyn, Thomas

AU - Fuller, William

AU - Pavlovic, Davor

AU - Swietach, Pawel

AU - Shattock, Michael J

PY - 2020/11/2

Y1 - 2020/11/2

M3 - Article

SN - 0008-6363

JO - Cardiovascular Research

JF - Cardiovascular Research

ER -